ep beat due tax share op inc miss guidanc flat
ep y/i line w/ expect notabl management expect oper perform
drive ep growth encourag may signifi turn point
remain sidelin demonstr consist op inc growth get
visibl partnership strategi
streetaccount thomson eikon cowen compani
report adj ep y/i ahead consensu
estim beat driven lower expect effect tax rate
estim contribut lower expect share count estim
net revenu y/i modestli ahead consensu
retail usa revenu y/i beat consensu
retail pharmaci revenu miss modestli pharmaci wholesal
revenu line
retail usa pharmaci compstore y/i same-stor prescript
y/i retail compstore y/i entir due continu de-emphasi tobacco
provid guidanc roughli flat y/i adj ep growth constant currenc
rate rang plu minu line consensu impli y/i
growth
management outlin number key driver guidanc includ reduct
bonu headwind adj ep adj effect tax rate headwind adj ep
net share repurchas tailwind adj ep oper perform
tailwind adj ep
pleas see page report import disclosur
market perform rate think compani weakli posit
transit toward value-bas care rel peer other pharma
suppli chain manag care industri consolid integr medic
pharmaci data stand still reliant tradit retail pharmaci
model believ leav expos potenti disrupt also
think ownership acquisit aet rather partnership open health
hub necessari realiz benefit cost trend improv without
see potenti margin distribut channel greater risk
disrupt furthermor manag consist meet exceed adj ep
estim fare well base oper metric think indic
challeng macro environ
y/i top-lin growth driven
script growth off-set gener
penetr fx headwind
margin pressur continu
share repo
y/i top-lin growth mid-singl
lower expect reimburs
faster expect realiz cost
share repo greater
greater expect margin pressur
slower expect realiz cost
walgreen oper largest drugstor chain compani sell product
servic retail drugstor mail telephon on-line
channel within store walgreen sell prescript non-prescript drug
well gener merchandis includ household item conveni fresh food
person care beauti care photo finish candi primarili within retail locat
walgreen oper take clinic walgreen also oper specialti infus
respiratori servic mail servic
management expect low-singl digit revenu growth same-stor prescript
growth similar back-half impli rang management also expect
challeng reimburs environ compar last three
year given number renew
management expect adj effect tax rate share repurchas
also expect invest
increment invest
increment posit given y/i adj ep growth oper
perform without headwind remov e-cigarett
think may signifi inflect point indic underli adj oper
incom growth posit addit convers management suggest
base year growth expect beyond benefit
transform management program compound realiz contribut
partnership also benefit lower leas expens compani
renegoti expir current leas favor market rate said
remain sidelin demonstr abil consist grow
oper basi get visibl store-in-stor partnership
strategi given earli inning implement partnership
announc would look construct abl demonstr
effect execut front particularli would provid us greater comfort
around management long-term adj ep guidanc mid- high-singl digit percentag growth
slightli lower adj ep estim slightli rais
adj ep estim rais price target
base revis dcf analysi impli share trade
million except per-shar data
compani report cowen compani
changevariancenet fifo cost fifo gross fifo gross bpsbp chang lifo lifo gross lifo gross bpsadjust bpsadjust equiti earn ab- na- adjust equiti earn adjust oper adjust oper bpsinterest expens pre-tax pre-tax bpsincom tax incom tax bpspost tax earn equiti method net earn non-controlling adjust net net averag dilut adjust cowen
million except per-shar data
cowen compani
model assumptionstermin growth tax depreci chang work terminal- capit valuefre pv npv free npv futur excess valu total number valu per year end august cowen
million except per-shar data
compani report cowen compani
fifo cost fifo gross fifo gross chang lifo lifo gross lifo gross equiti earn ab- adjust equiti earn adjust oper adjust oper expens pre-tax pre-tax tax incom tax tax earn equiti method net earn non-controlling adjust net total net averag dilut adjust chang gross gross oper year end august cowen
million except per-shar data
compani report cowen compani
fifo cost fifo gross fifo gross chang lifo lifo gross lifo gross equiti earn ab- adjust equiti earn adjust oper adjust oper expens pre-tax pre-tax tax report incom tax incom tax tax earn equiti method net earn non-controlling adjust net total net averag dilut adjust chang gross gross oper cowen
million
compani report cowen compani
asset cash account receiv current current properti intang non-curr total current liabil short-term trade account accru expens incom current long-term defer incom non-curr stockhold equiti common paid-in employe stock loan receivable- retain accumul comprehens treasuri non-controlling total stockhold total liabil stockhold short-term liquid ratio current sale purchas acct ratio inventori structur long-term solvenc ratio total debt total interest ratio return invest capit averag total asset averag stockhold equiti year end august cowen
million
compani report cowen compani
income/ loss flow oper activ depreci gain previous held equiti interest- share base compens unreal gain fair valu adjustments- defer incom invest impair chang oper asset liabil receiv current non-curr account accru expens incom non-curr net cash oper acquisit properti acquisit issuanc common purchas treasuri dividend proceeds/ purchas secur proceeds/ repay debt net increase/ decreas cash equival begin cash equival end cowen summari oper capit owner financ non-recur exclud non-recur itemsfor year end august cowen
million
compani report cowen compani
flow oper activ net adjust reconcil net earn net cash depreci loss allianc boot call option- sale defer incom stock compens incom tax save employe stock plans- chang oper asset liabil account receiv current trade account accru expens incom non-curr asset net cash provid oper flow invest activitiesaddit properti proce sale leaseback transactions- purchas short-term invest held proce short-term invest held purchas short-term invest avail sale- proce sale short-term invest avail sale- return invest restrict cash- proce sale busi intang asset acquisit net cash payment proce sale invest invest allianc net cash use invest flow financ activitiesnet payment short-term payment long-term proce financ leases- issuanc long-term stock proce relat employe stock dividend net cash provid use financ effect exchang rate chang cash cash chang equivalentsnet decreas cash cash cash equival begin cash equival end year end august cowen
use five-year discount cash flow analysi primari valuat method
deriv price target gener assum discount rate may appli
appropri adjust depend compani and/or industri specif factor also
assum termin growth rate depend long-term view specif
sub-industri coverag note discount rate assumpt could view
conserv rel actual weight averag cost capit view
assumpt reason long run lower discount rate assumpt
increas termin growth rate assumpt would lead higher estim valu
per share secondari measur look forward price-to-earnings multipl ev/sal ratio
impli dcf analysi compar histor averag
see number risk associ drug retail space industri highli
competit retail drugstor chain independ pharmaci mail-ord provid
well retail includ groceri store mass merchant warehous club on-line
store compet space could pressur front-end sale margin
current wave drug patent expir posit impact profit
deriv gener expect taper significantli next sever year
specialti provid signific tailwind part believ
could concern around sustain high growth area
believ impact ppaca expect increas volum could subdu
depend implement execut
number company-specif risk associ pt includ loss
share disrupt entiti wors expect reimburs pressur better
expect gener procur wbad meaning acquisit
